
Clive N. Svendsen, PhD
Research
No patient rating & comments.
Why?
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.

No patient rating & comments.
Why?
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
Clive N. Svendsen, PhD
Research
No patient rating & comments.
Why?
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.

Clive N. Svendsen, PhD
Research
Languages
- English,
Gender
Male
Experience
31 Years
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
1
- Research
Programs
Cedars-Sinai clinical programs this provider is part of:
1
Research Areas
Titles
- Professor, Biomedical Sciences
- Director, Board of Governors Regenerative Medicine Institute
- Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine
- Executive Director, Board of Governors Regenerative Medicine Institute
- Professor, Medicine
Education & Training
-
Jesus College, Cambridge
Degrees - Completed 1991
-
King's College London
Degrees - Completed 1983
Achievements
-
6
Awards and Honors
-
4
Publications
Awards and Honors
- Board, Emulate Incorporated, Organ on a Chip Company
- Huntington Disease Trailblazer Award, Huntington’s Disease Society of America
- Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine
- Shelia Essey Award, American Academy of Neurology
- Bernard Sanberg Memorial Award for Brain Repair
- Statuette Award, International Academy for Child Brain Development
Publications
- Thomsen GM, Gowing, Latter J, Chen M, Vit JP, Staggenborg K, Avalos P, Alkaslasi M, Ferraiuolo L, Likhite S, Kaspar BK, Svendsen CN. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. J Neurosci. 2014;34:15587-600.
- Lu XH, Mattis VB, Wang N, Al-Ramahi I, van den Berg N, Fratantoni SA, Waldvogel H, Greiner E, Osmand A, Elzein K, Xiao J, Dijkstra S, de Pril R, Vinters HV, Faull R, Signer E, Kwak S, Marugan JJ, Botas J, Fischer DF, Svendsen CN, et al. Targeting ATM ameliorates mutant Huntington toxicity in cell and animal models of Huntington’s disease. Sci Transl Med. 2014;6(268):268ra178.
- Lu B, Lin Y, Tsai Y, Girmans S, Adamus G, Jones MK, Shelley B, Svendsen C, Wang S. A Subsequent Human Neural Progenitor Transplant in to the Degenerate Retina Does Not Compromise Initial Graft Survival or Therapeutic Efficacy. PLoS One. 2015;4(1):7.
- Kong SY, Park MH, Lee M, Kim JO, Lee HR, Han BW, Svendsen CN, Sung SH, Kim HJ. Kuwanon v inhibits proliferation, promotes cell survival and increases neurogenesis of neural stem cells. PLoS One. 2015;10(2):e0118188.